Stocks Comparison
Parsons vs Science Applications International: revenue, profit, margins and growth compared
Parsons brought in $6.4B of revenue in fiscal 2025, Science Applications International $7.3B in fiscal 2026. Revenue changed by -5.7% at Parsons and -2.9% at Science Applications International on the year before, so Science Applications International grew faster. Parsons kept 3.8% of its revenue as net profit, Science Applications International 4.9%. Free cash flow was $410.4M at Parsons and $577M at Science Applications International.
Side by side, latest fiscal year
| PSN | SAIC | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (January 30, 2026) |
| Revenue | $6.4B | $7.3B |
| Revenue growth | -5.7% | -2.9% |
| Net income | $241.1M | $358M |
| Net margin | 3.8% | 4.9% |
| Free cash flow | $410.4M | $577M |
| Free cash flow margin | 6.4% | 7.9% |
| Earnings per share (diluted) | $2.20 | $7.70 |
| Cash | $466.4M | $182M |
| Debt | $1.2B | $2.5B |
| Price to earnings | 19.6 | 17.2 |
| Market value | $4.6B | $5.6B |
| Dividend yield | n/a | 0.28% |
| Rank by revenue in sector | #77 of 530 · Technology | #65 of 530 · Technology |
Over the years
Questions about Parsons and Science Applications International
Which is bigger by revenue, Parsons or Science Applications International?
Science Applications International is bigger by revenue: $7.3B in fiscal 2026, against $6.4B for Parsons in fiscal 2025.
Which keeps more of its revenue as profit, Parsons or Science Applications International?
Parsons had a net margin of 3.8% in fiscal 2025; Science Applications International had 4.9% in fiscal 2026.
Which grew revenue faster, Parsons or Science Applications International?
In their latest fiscal years revenue changed by -5.7% at Parsons and -2.9% at Science Applications International.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.